Chemicals Industry Today

Microcrystalline Cellulose Market to Reach USD 1,860.0 Billion by 2032 | CAGR of 8.66%

This market is expanding as Microcrystalline Cellulose (MCC) remains a key pharmaceutical excipient due to its compressibility, flowability, and chemical inertness. MCC is vital for tablet formulation and is seeing rising use across generic and branded drug manufacturing.
Published 10 June 2025

The microcrystalline cellulose (MCC) market as a pharmaceutical excipient is experiencing significant growth. According to a report by WiseGuyReports, the market size was estimated at USD 880.62 billion in 2023 and is projected to reach USD 1,860.0 billion by 2032, growing at a compound annual growth rate (CAGR) of 8.66% during the forecast period from 2024 to 2032.

Market Overview

Microcrystalline cellulose is a refined wood pulp used as a texturizer, anti-caking agent, fat substitute, emulsifier, extender, and bulking agent in food production. In the pharmaceutical industry, MCC is widely utilized as an excipient due to its inertness, compressibility, and ability to control drug release rates. It is commonly used in tablet formulations, capsules, and other oral dosage forms.

Key Market Drivers

Increasing Demand for Generic Drugs

The rising prevalence of chronic diseases and the growing population of geriatric patients have led to an increase in the demand for cost-effective generic medications. Microcrystalline cellulose is widely used as a pharmaceutical excipient in generic drug formulations, providing the necessary inert and cohesive properties required for effective drug delivery.

Technological Advancements in Drug Delivery Systems

Ongoing advancements in drug delivery technologies have created new opportunities for the use of microcrystalline cellulose as a pharmaceutical excipient. The development of novel drug delivery systems, such as controlled-release formulations and targeted drug delivery systems, requires the use of excipients that can provide the desired release profiles and stability. Microcrystalline cellulose's unique properties make it suitable for these applications.

Focus on Patient Compliance

The increasing emphasis on patient compliance has driven the demand for pharmaceutical formulations that are easy to administer and have improved patient acceptance. Microcrystalline cellulose's properties, such as its ability to improve tablet hardness and disintegration, contribute to the development of formulations that enhance patient compliance.

Download Exclusive Sample Copy of this Report here: https://www.wiseguyreports.com/sample-request?id=563749 

Market Segmentation

The microcrystalline cellulose as pharmaceutical excipient market is segmented based on type, functionality, delivery formulations, end-use applications, and region.

By Type:

  • Pharmaceutical Grade: Used in drug formulations.
  • Food Grade: Used in food products.
  • Cosmetic and Personal Care Grade: Used in cosmetic products.
  • Industrial Grade: Used in industrial applications.

By Functionality:

  • Binder: Provides cohesiveness to tablet formulations.
  • Disintegrant: Facilitates the breakup of tablets upon ingestion.
  • Filler: Adds bulk to formulations.
  • Lubricant: Reduces friction during tablet compression.
  • Glidant: Improves powder flow properties.

By Delivery Formulations:

  • Tablets: Solid dosage forms.
  • Capsules: Gelatin or vegetarian capsules.
  • Injectable Suspensions: Liquid formulations for injection.
  • Ointments: Semisolid formulations for topical application.
  • Creams: Emulsions for topical application.

By End-Use Applications:

  • Diabetes Management: Formulations for diabetes treatment.
  • Gastrointestinal Disorders: Formulations for digestive system ailments.
  • Cardiovascular Diseases: Formulations for heart-related conditions.
  • Neurological Disorders: Formulations for brain and nervous system conditions.
  • Oncology: Formulations for cancer treatment.

By Region:

  • North America: United States, Canada, and Mexico.
  • Europe: Germany, France, United Kingdom, and others.
  • South America: Brazil, Argentina, and others.
  • Asia Pacific: China, Japan, India, and others.
  • Middle East and Africa: United Arab Emirates, Saudi Arabia, South Africa, and others.

Buy Now & Get Exclusive Discount on this Report: https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=563749 

Key Companies in the Microcrystalline Cellulose As Pharmaceutical Excipient Market Include:

  • The Dow Chemical Company
  • Blanver
  • Roquette Freres
  • Ashland
  • Kimica Corporation
  • JRS Pharma
  • Mingtai Chemical

Browse Related Reports:

Truck Bed Liners MarketJapanese|German|French|Korean|Chinese|Spanish

Tripropylamine MarketJapanese|German|French|Korean|Chinese|Spanish

Zinc White Copper Strip MarketJapanese|German|French|Korean|Chinese|Spanish

Whey Hydrolysate MarketJapanese|German|French|Korean|Chinese|Spanish

Frp Sheet And Panel MarketJapanese|German|French|Korean|Chinese|Spanish

Browse Regional Related Report:

医薬品添加剤としての微結晶セルロース市場レポート | Marktbericht für mikrokristalline Cellulose als pharmazeutischer Hilfsstoff | Rapport sur le marché de la cellulose microcristalline comme excipient pharmaceutique | 의약용 첨가제로서의 미결정성 셀룰로오스 시장 보고서 | 药用辅料微晶纤维素市场报告 | Informe del mercado de celulosa microcristalina como excipiente farmacéutico


Other Industry News

Ready to start publishing

Sign Up today!